Patents by Inventor Yuan-Ching Phoebe Chiang

Yuan-Ching Phoebe Chiang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oxamic acids and derivatives as thyroid receptor ligands
    Publication number: 20030114521
    Abstract: The present invention provides novel compounds of the Formula 1
    Type: Application
    Filed: December 20, 2002
    Publication date: June 19, 2003
    Inventors: Yuan-Ching Phoebe Chiang, Robert L. Dow
  • Oxamic acids and derivatives as thyroid receptor ligands
    Patent number: 6545018
    Abstract: The present invention provides novel compounds of the Formula and prodrugs thereof, geometric and optical isomers thereof, and pharmaceutically acceptable salts of such compounds, prodrugs and isomers, wherein R1-R8 and W are as described herein. Pharmaceutical compositions containing such compounds, prodrugs, isomers or pharmaceutically acceptable salts thereof, and methods, pharmaceutical compositions and kits for treating obesity, hyperlipidemia, glaucoma, cardiac arrhythmia, skin disorders, thyroid disease, hypothyroidism and related disorders and diseases such as diabetes mellitus, atherosclerosis, hypertension, coronary heart disease, hypercholesteremia, depression and osteoporosis are also provided.
    Type: Grant
    Filed: September 27, 2001
    Date of Patent: April 8, 2003
    Assignee: Pfizer Inc.
    Inventors: Yuan-Ching Phoebe Chiang, Robert L. Dow
  • Oxamic acids and derivatives as thyroid receptor ligands
    Publication number: 20020049226
    Abstract: The present invention provides novel compounds of the Formula 1
    Type: Application
    Filed: September 27, 2001
    Publication date: April 25, 2002
    Inventors: Yuan-Ching Phoebe Chiang, Robert L. Dow
  • Oxamic acids and derivatives as thyroid receptor ligands
    Patent number: 6326398
    Abstract: The present invention provides novel compounds of the Formula and prodrugs thereof, geometric and optical isomers thereof, and pharmaceutically acceptable salts of such compounds, prodrugs and isomers, wherein R1-R8 and W are as described herein. Pharmaceutical compositions containing such compounds, prodrugs, isomers or pharmaceutically acceptable salts thereof, and methods, pharmaceutical compositions and kits for treating obesity, hyperlipidemia, glaucoma, cardiac arrhythmia, skin disorders, thyroid disease, hypothyroidism and related disorders and diseases such as diabetes mellitus, atherosclerosis, hypertension, coronary heart disease, hypercholesteremia, depression and osteoporosis are also provided.
    Type: Grant
    Filed: February 28, 2000
    Date of Patent: December 4, 2001
    Assignee: Pfizer Inc.
    Inventors: Yuan-Ching Phoebe Chiang, Robert L. Dow